Dead cat bounce for Geron? Maybe. With only GRN1005 and maybe a small, very small chance that the last two trial with imetelstat may work I can't put much hope in this company. So I sold 1000 shares at $1.30 for a $400 loss and sold 10 $1 covered calls for Mar 2013 for 55 cents, that would be a $1500 loss. I'm still going to keep 3-5 thousand shares till the GRN1005 trials are over and results are known. I can't believe a Geron could be 100% wrong on everything they have done. Even a blind squirrel finds a nut once in a while.
Geron was up 7 cents to close at $1.33 on 2.8 million shares. The three month avg. volume is 1.3 million shares.
Remember the last two imetelstat trial are going for the side effects of imetelstat that helps lower the red blood count, [I may have that a little wrong but it's the side effect of imetelstat, Geron is hoping that will work].
ACTC, I thought was going to move up, but it closed down a little at 0.0845 on 9.4 million shares. The three month avg volume is 5 million shares. ACTC is the future in bio-tech.
AAPL iPhone 5 and it's up 9.20 to closed at $669.79 on 24.7 million shares. We go higher.
Good luck in this rigged casino,
No comments:
Post a Comment